Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05894_nanopub.RAILeocpLZd5YRXF3VvH23hNeQhXS7JNVmnT7dUj5pidk#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05894 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05894 label "GT 389-255 [drugbank:DB05894]" assertion.
- drugbank:DB05894 seeAlso DB05894 assertion.
- drugbank:DB05894 description "Peptimmuneâs lead product GT 389-255, is a novel lipase inhibitor and fat binding hydrogel polymer conjugate for the treatment of obesity which has completed single and multiple ascending dose (SAD and MAD) Phase I trials. It is expected to block fat absorption with fewer side effects than currently marketed lipase inhibitors." assertion.
- drugbank:DB05894 identifier "drugbank:DB05894" assertion.
- drugbank:DB05894 title "GT 389-255" assertion.
- drugbank:DB05894 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05894 drugbank_vocabulary:drugbank-id "DB05894" assertion.
- drugbank:DB05894 bio2rdf_vocabulary:x-identifiers.org DB05894 assertion.
- drugbank:DB05894 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05894" assertion.
- drugbank:DB05894 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05894 bio2rdf_vocabulary:identifier "DB05894" assertion.